The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Programmed cell death 1 (PD-1) and its ligand (PD-L1) in common cancers and their correlation with molecular cancer type.
Zoran Gatalica
Employment or Leadership Position - Caris Life Sciences
Stock Ownership - Caris Life Sciences
Anatole Ghazalpour
Employment or Leadership Position - Caris Life Sciences
Stock Ownership - Caris Life Sciences
Daniel Holterman
Employment or Leadership Position - Caris Life Sciences
Nianqing Xiao
Employment or Leadership Position - Caris Life Sciences
Peggy Overberg
Employment or Leadership Position - Caris Life Sciences
Inga Rose
Employment or Leadership Position - Caris Life Sciences
Gargi Dan Basu
Employment or Leadership Position - Caris Life Sciences
Daniel D. Von Hoff
Employment or Leadership Position - Caris Life Sciences
Stock Ownership - Caris Life Sciences
Omid Hamid
No relevant relationships to disclose